Title : Inhibitory effect of amiloride on the urokinase plasminogen activators in prostatic cancer.

Pub. Date : 1998

PMID : 9422083






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibitory effect of amiloride on the urokinase plasminogen activators in prostatic cancer. Amiloride plasminogen activator, urokinase Rattus norvegicus
2 The diuretic drug amiloride (AMLD), which competitively inhibits the catalytic activity of urokinase plasminogen activators (UPA), was used to study its effects on the proteolytic enzymes implicated in the invasiveness and metastases in a prostatic tumor model carrying two different sublines of adenocarcinoma of the prostate. Amiloride plasminogen activator, urokinase Rattus norvegicus
3 The diuretic drug amiloride (AMLD), which competitively inhibits the catalytic activity of urokinase plasminogen activators (UPA), was used to study its effects on the proteolytic enzymes implicated in the invasiveness and metastases in a prostatic tumor model carrying two different sublines of adenocarcinoma of the prostate. Amiloride plasminogen activator, urokinase Rattus norvegicus